Roswell Park moving unique immunotherapy platform forward with $6.42 million DoD grant
A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a DoD grant. The four-year, $6.42 million Breakthrough Award will fund a clinical trial in patients with brain-metastatic breast cancer. September 18, 2019